Remote monitoring technology can expand the reach of clinical trials, says Jennifer Price, executive director of data and analytics at THREAD.
The feedback is revenue and reimbursement aren’t rising at the same rate as cost, says Ben Albert, CEO of Health Catalyst.
Matthew Laskowski, CEO of Toby, discusses the machine learning and biomarker analysis technology behind the company’s urine-based multi-cancer detection test that has received FDA Breakthrough Device designation in the United States.
To get ROI, execs need to apply technology at scale, says former HCA CFO Bill Rutherford, who is now on the Board of Mangers at Ensemble Health Partners.
